Results 91 to 100 of about 1,889,217 (290)
The biomedical informatics short course at Woods Hole/Georgia: Training to support institutional change. [PDF]
Inf Serv Use, 2022 Cimino JJ.
europepmc +1 more source
Informal Institutions, Institutional Change, and Gender Equality [PDF]
Political Research Quarterly, 2013 This paper makes two claims: insights from gender research improve understandings of informal institutions and institutional change, and studying informal institutions helps scholars understand the gap between formal institutional change and outcomes.
openaire +5 more sources
Introduction to Organization, Leadership, and Change in ODDE: The Critical Importance of Institutional Leadership [PDF]
, 2022 Ross Paul
openalex +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Molecular Oncology, EarlyView.Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Image and Substance Failures in Regional Organisations: Causes, Consequences, Learning and Change?
Politics and Governance, 2016 States often pool their sovereignty, capacity and resources to provide regionally specific public goods, such as security or trade rules, and regional organisations play important roles in international relations as institutions that attempt to secure ...
Meng Hsuan Chou +2 more
doaj +1 more source
Molecular Oncology, EarlyView.Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
The impact of socio-economic institutional change on agricultural carbon dioxide emission reduction in China. [PDF]
PLoS One, 2021 Long DJ, Tang L.
europepmc +1 more source